Acute Kidney Injury
AKI hospitalizations were 4 times more likely among patients with diabetes.
Balanced crystalloids decreases adverse kidney events compared to saline among critically ill patients: The SMART trialMarch 07, 2018
1. Use of balanced crystalloids (lactated Ringers or Plasma-Lyte A) was associated with a significant reduction in acute kidney injury events compared to normal saline among intensive care unit (ICU) patients. 2. Use of balanced crystalloids was also associated with lower though nonsignificant in-hospital mortality at 30-days after admission. Evidence Rating Level: 1 (Excellent) Study 
No patient had a 25% or greater rise in serum creatinine 48 hours after receiving a median 13 mL of contrast for diagnostic coronary angiography, with an additional 13 mL for percutaneous coronary intervention.
AKI associated with 27% increased risk of hypoglycemia among patients with diabetes.
High risk of AKI in first year after non-kidney solid organ transplant; in turn, increases CKD risk.
Early and late initiation of renal replacement therapy for AKI in critically ill patients are associated with similar long-term risks of death, chronic kidney disease, and end-stage renal disease.
Though hospital admission rates have increased, inpatient death has improved from 2003 to 2012.
Among patients admitted to a coronary care unit, the highest quartile of serum cystatin C levels was associated with a 9.6-fold increased risk of AKI compared with the lowest quartile.
Dabigatran and rivaroxaban were associated with lower risks of adverse renal outcomes compared with warfarin.
In a study of hospitalized US veterans, AKI was associated with a 23% increased risk of heart failure compared with the absence of AKI.
The model was based on 6 variables readily obtained at hospital discharge.
Contrast-associated acute kidney injury occurred in 9.5% and 9.1% of patients receiving IV sodium bicarbonate and acetylcysteine, respectively, rates which did not differ significantly from the 8.3% rate among those receiving IV sodium chloride.
From 2004 to 2012, the incidence of AKI increased from 4.9% to 14.2% among CABG patients and from 2.7% to 8.8% among PCI patients.
In a phase 3 trial, acute kidney injury developed in 13.2% of patients undergoing invasive coronary angiography compared with 5.6% of those undergoing computed tomography angiography.
In a study, end-stage renal disease developed in 56% of patients discharged from a hospital with acute kidney injury requiring dialysis.
Timing of AKI after urgent percutaneous coronary intervention affects risk of significant kidney function loss 1 year after the procedure.
Post hoc analysis of SPRINT finds no significant difference in the incidence of fatal and nonfatal cardiovascular events among patients with moderate-to-advanced chronic kidney disease.
In a study, AKI sufferers had an increased rate of venous thromboembolism whether they receive heparin prophylaxis or not.
Three-quarters of patients hospitalized with acute kidney injury in Alberta, Canada did not visit a kidney specialist within 12 months of discharge.
Elevated levels of the two proteins can predict risk of acute kidney injury.
Risk of AKI in hospitalized children higher than with IV vancomycin, other antipseudomonal -lactam
AKI occurred with similar frequency among patients who did and did not receive contrast medium.
Findings do not suggest an increased risk of AKI associated with SGLT2 inhibitor use in patients with type 2 diabetes.
Higher mortality was seen in association with an emergency department discharge with acute kidney injury vs no acute kidney injury.
Myocardial infarction patients who underwent percutaneous coronary intervention had an AKI rate similar to those who did not have the procedure.
Evidence to date provides no clear answer as to whether early or delayed RRT is the best approach.
Chronic kidney disease and anemia are associated with an increased risk for acute kidney injury in patients with pulmonary embolism.
Of the children who developed acute kidney injury, 34.9% had stage 1, 45.3% had stage 2, and 19.8% had stage 3.
An increase in injury and repair biomarker levels suggests structural damage to renal tubules occurring after marathon.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)